NICOLE Junkermann has been appointed as a new Trustee of The Royal Marsden Cancer Charity, which supports the work of The Royal Marsden NHS Foundation Trust, a world-leading cancer centre.
Nicole, who is an entrepreneur and investor, brings extensive experience to her new role, which she took up in January.
As Vice-Chairperson of Infront Sports & Media, Nicole helped build the company into a top sports and media rights business, later acquired by Bridgepoint Capital in 2011.
Nicole founded United in Sports, her own private equity fund focused on sports and media investments, which raised approximately €250m. She also served for four years as an Advisor to pan-European private equity firm, Trilantic Europe.
Nicole is the Principal and owner of NJF Capital, which invests in a wide portfolio of innovative businesses, including biotech companies Owkin, Cambrian Biopharma, and Gordian Biotechnology. Nicole sits on the Tate Americas Foundation Latin American Acquisitions Committee, supporting the work of Latin American artists. In August 2023, she was appointed a Trustee of the Royal Academy Trust.
“It is a real privilege to join The Royal Marsden Cancer Charity as a Trustee; it is an organisation with a mission especially close to my heart.
“I am excited and humbled to have the opportunity to contribute to the Charity’s incredible work, which supports world-leading specialists in their fields.
“We live in a time of extraordinary progress in technology, in particular artificial intelligence, which has the potential to fundamentally transform medicine and the delivery of healthcare. I hope to draw on my experience in this sector to help The Royal Marsden Cancer Charity continue to fund world-leading research and the very best treatment and care for cancer patients.”
Antonia Dalmahoy, Managing Director of The Royal Marsden Cancer Charity, said:
“I’m delighted to welcome Nicole Junkermann as a Trustee of The Royal Marsden Cancer Charity. Her experience and expertise from her work across the globe will be hugely beneficial to the charity’s efforts, and I look forward to working with Nicole alongside our other Trustees to ensure The Royal Marsden Cancer Charity continues to make a vital difference to cancer patients globally.”